RU2187333C2 - Вакцина для защиты свиней от репродуктивного и респираторного синдрома и способ защиты свиней - Google Patents

Вакцина для защиты свиней от репродуктивного и респираторного синдрома и способ защиты свиней Download PDF

Info

Publication number
RU2187333C2
RU2187333C2 RU98118186/13A RU98118186A RU2187333C2 RU 2187333 C2 RU2187333 C2 RU 2187333C2 RU 98118186/13 A RU98118186/13 A RU 98118186/13A RU 98118186 A RU98118186 A RU 98118186A RU 2187333 C2 RU2187333 C2 RU 2187333C2
Authority
RU
Russia
Prior art keywords
virus
vaccine
neb
prrs
reproductive
Prior art date
Application number
RU98118186/13A
Other languages
English (en)
Russian (ru)
Other versions
RU98118186A (ru
Inventor
Ричард ХЕССИ
Original Assignee
Шеринг Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24442410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2187333(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Шеринг Корпорейшн filed Critical Шеринг Корпорейшн
Publication of RU98118186A publication Critical patent/RU98118186A/ru
Application granted granted Critical
Publication of RU2187333C2 publication Critical patent/RU2187333C2/ru

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
RU98118186/13A 1996-03-01 1997-02-26 Вакцина для защиты свиней от репродуктивного и респираторного синдрома и способ защиты свиней RU2187333C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60980696A 1996-03-01 1996-03-01
US08/609,806 1996-03-01

Publications (2)

Publication Number Publication Date
RU98118186A RU98118186A (ru) 2000-08-20
RU2187333C2 true RU2187333C2 (ru) 2002-08-20

Family

ID=24442410

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98118186/13A RU2187333C2 (ru) 1996-03-01 1997-02-26 Вакцина для защиты свиней от репродуктивного и респираторного синдрома и способ защиты свиней

Country Status (19)

Country Link
EP (1) EP0894007A1 (de)
JP (1) JP3135069B2 (de)
KR (1) KR100297537B1 (de)
CN (1) CN1165342C (de)
AR (1) AR006023A1 (de)
AU (1) AU2277497A (de)
BG (1) BG64693B1 (de)
BR (1) BR9708443B1 (de)
CA (1) CA2248182C (de)
CO (1) CO4600644A1 (de)
CZ (1) CZ273798A3 (de)
EE (1) EE04741B1 (de)
HU (1) HUP9901958A3 (de)
MY (1) MY115070A (de)
PL (1) PL328627A1 (de)
RU (1) RU2187333C2 (de)
SK (1) SK119498A3 (de)
WO (1) WO1997031651A1 (de)
ZA (1) ZA971663B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053787A1 (en) 1999-03-08 2000-09-14 Id-Lelystad, Instituut Voor Dierhouderij En Dierg Ezondheid B.V. Prrsv vaccines
EP0839912A1 (de) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Ansteckende Klone von RNA-Viren und darauf basierende Impfstoffe und diagnostisches Verfahren
NZ501264A (en) 1998-12-22 2001-09-28 Pfizer Prod Inc Polynucleotide DNA sequence encoding an infectious RNA molecule encoding a North American PRRS
DK1183332T3 (da) 1999-04-22 2010-09-06 Us Agriculture Porcint Reproduktions- og Respirations Syndrom-vaccine baseret på isolere JA-142
BRPI0510928A (pt) 2004-06-18 2007-11-13 Univ Minnesota identificação de organismos viralmente infectados e vacinados
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
UA95778C2 (ru) 2005-06-24 2011-09-12 Риджентс Оф Зе Юниверсити Оф Миннесота Вирусы репродуктивно-респираторного синдрома свиней, их инфекционные клоны и мутанты и способы применения
CN101612395B (zh) * 2008-06-24 2012-02-08 扬州优邦生物制药有限公司 一种培养敏感细胞生产蓝耳病疫苗的方法
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
MY186535A (en) 2011-02-17 2021-07-26 Boehringer Ingelheim Vetmedica Gmbh Novel european prrsv strain
WO2012110490A1 (en) 2011-02-17 2012-08-23 Boehringer Ingelheim Vetmedica Gmbh Commercial scale process for production of prrsv
US9315781B2 (en) 2011-07-29 2016-04-19 Boehringer Ingelheim Vetmedica Gmbh Infectious CDNA clone of european PRRS virus and uses thereof
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
KR101300528B1 (ko) * 2011-10-05 2013-09-02 캔 테크놀로지스 인코포레이티드 액티노바실러스 플루로뉴모니애 감염 방지 및 처치용 조성물
EP2968513A2 (de) 2013-03-15 2016-01-20 Boehringer Ingelheim Vetmedica, Inc. Prrs-virus, zusammensetzungen, impfstoff und verfahren zur verwendung
CZ309704B6 (cs) * 2020-12-10 2023-08-09 Univerzita Palackého v Olomouci Transportní médium pro transport a skladování virů
EP4012025A1 (de) * 2020-12-10 2022-06-15 Univerzita Palackého v Olomouci Transportmedium für nukleinsäuren- und/oder proteinhaltige proben

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042830A (en) * 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
JPH07501049A (ja) * 1991-10-14 1995-02-02 アクゾ・ノベル・エヌ・ベー ブタ生殖・呼吸系症候群ワクチン及び診断方法
FR2686097B1 (fr) * 1992-01-14 1994-12-30 Rhone Merieux Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
ES2152304T3 (es) * 1993-02-08 2001-02-01 Bayer Ag Procedimiento para el crecimiento del virus del sindrome reproductivo y respiratorio porcino y su uso en vacunas.
ES2074950B1 (es) * 1993-09-17 1996-03-16 Iberica Cyanamid Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
ES2165405T3 (es) * 1994-04-11 2002-03-16 Akzo Nobel Nv Cepas de vacuna europeas del virus del sindrome reproductor y respiratorio porcino (prrsv).
US5690940A (en) * 1995-06-21 1997-11-25 Regents Of The University Of Minnesota Low pathogencity PRRS live virus vaccines and methods of preparation thereof

Also Published As

Publication number Publication date
MY115070A (en) 2003-03-31
BR9708443B1 (pt) 2012-06-12
BR9708443A (pt) 1999-08-03
CN1165342C (zh) 2004-09-08
WO1997031651A1 (en) 1997-09-04
EE9800267A (et) 1999-02-15
EP0894007A1 (de) 1999-02-03
AR006023A1 (es) 1999-07-21
CA2248182C (en) 2004-04-20
AU2277497A (en) 1997-09-16
MX9807083A (es) 1998-12-31
BG64693B1 (bg) 2005-12-30
HUP9901958A2 (hu) 1999-10-28
CN1216922A (zh) 1999-05-19
JP3135069B2 (ja) 2001-02-13
HUP9901958A3 (en) 2000-04-28
PL328627A1 (en) 1999-02-15
SK119498A3 (en) 1999-07-12
JPH11506122A (ja) 1999-06-02
BG102809A (en) 1999-05-31
KR19990087432A (ko) 1999-12-27
EE04741B1 (et) 2006-12-15
KR100297537B1 (ko) 2001-10-26
CO4600644A1 (es) 1998-05-08
CZ273798A3 (cs) 1999-02-17
ZA971663B (en) 1997-08-26
CA2248182A1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
US5866401A (en) Porcine reproductive and respiratory syndrome vaccine
RU2192887C2 (ru) Вакцина против репродуктивного и респираторного синдрома свиней (prrs), способ иммунизации свиньи против prrs, способ получения вакцины, выделенный и очищенный штамм вируса репродуктивного и респираторного синдрома свиней
RU2187333C2 (ru) Вакцина для защиты свиней от репродуктивного и респираторного синдрома и способ защиты свиней
McFerran et al. Studies on immunisation of pigs with the Bartha strain of Aujeszky’s disease virus
Wensvoort et al. Bovine viral diarrhoea virus infections in piglets born to sows vaccinated against swine fever with contaminated vaccine
EP0676467B1 (de) Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Schweins
EP0830142B1 (de) Prrs-(porcine reproductive and respiratory syndrome)-virusvakzin
KR100241221B1 (ko) 돼지 불임 및 호흡기계 중후백신 및 그의 진단법
EP0345911B1 (de) Hundecoronavirus
US5510258A (en) Porcine reproductive and respiratory syndrome virus antigen and processes for the preparation and use of said antigen in vaccines and diagnostics
RU2335298C2 (ru) Способ вакцинации против инфекции семенников bvdv
Aynaud Principles of vaccination
RU2403061C1 (ru) Вакцина инактивированная комбинированная против инфекционного ринотрахеита, парагриппа-3, респираторно-синцитиальной болезни, вирусной диареи и пастереллеза крупного рогатого скота
RU2269361C2 (ru) Вакцина ассоциированная эмульсионная инактивированная против репродуктивно-респираторного синдрома и парвовирусной инфекции свиней
RU2395297C1 (ru) Вакцина инактивированная комбинированная против инфекционного ринотрахеита, вирусной диареи и лептоспироза крупного рогатого скота
Nauwynck et al. Efficacy of an Intranasal Immunization with gEgC and gEgI Double‐deletion Mutants of Aujeszky’s Disease Virus in Maternally Immune Pigs and the Effects of a Successive Intramuscular Booster with Commercial Vaccines
KR20240028924A (ko) 높은 중화 항체를 유도하는 돼지 유행성 설사병 바이러스 및 불활화 백신 조성물
Pensaert Porcine epidemic diarrhea
MXPA98007083A (en) Vaccine against the reproductive and respiratory syndrome porc
JPH0463862B2 (de)
MXPA97010149A (en) Live pathogenicity live virus vaccines and methods of preparation of mis

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner